While several reports have shown that loss of RB1 is found in more than 90% of clinical SCLCs [12], 100% (5/5) of SCLC samples examined here were RB1-negative when classified by the CCND1/CDKN2A expression assay. The gene discussed is CCND1; the disease is small cell lung carcinoma.